Deltaspharma India Profile
Key Indicators
- Authorised Capital ₹ 4.95 Cr
- Paid Up Capital ₹ 4.95 Cr
- Company Age 6 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.38 Cr
- Revenue Growth 19.39%
- Profit Growth 104.83%
- Ebitda 10.76%
- Net Worth 0.40%
- Total Assets -12.36%
About Deltaspharma India
Deltaspharma India Private Limited (DIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2019 (Six years 8 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.95 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹7.38 Cr.
Sureshkumar Jain, Babuulal Jain, Aasinkumar Maurya, and One other member serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290MH2019PTC321346
- Company No.
321346
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2019
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Deltaspharma India Private Limited offer?
Deltaspharma India Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Child and Baby Care Products, Baby Creams & Lotion, Juices, Soups & Soft Drinks, Instant Drink Mix, Ayurvedic Tablets, Sexual Wellness Products.
Who are the key members and board of directors at Deltaspharma India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sureshkumar Jain  | Director | 15-Feb-2019 | Current |
| Babuulal Jain | Director | 15-Feb-2019 | Current |
| Aasinkumar Maurya | Director | 15-Feb-2019 | Current |
| Milankumar Jain | Director | 13-Apr-2019 | Current |
Financial Performance of Deltaspharma India.
Deltaspharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.39% increase. The company also saw a substantial improvement in profitability, with a 104.83% increase in profit. The company's net worth moved up by a moderate rise of 0.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deltaspharma India?
In 2023, Deltaspharma India had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Toptime Consumer Private LimitedSureshkumar Jain, Babuulal Jain and 1 more are mutual person
Magestic Premises Private LimitedSureshkumar Jain and Babuulal Jain are mutual person
- Meridian Buildpro Private Limited
Sureshkumar Jain and Babuulal Jain are mutual person
- Divine Depute Private Limited
Sureshkumar Jain and Babuulal Jain are mutual person
- Deltaspharrma Private Limited
Babuulal Jain is a mutual person
- Padmavati Enterprises Private Limited
Babuulal Jain is a mutual person
Charges (Loans)
₹7.38 Cr
₹0
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 7.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2020 | Karnataka Bank Ltd. | ₹2.63 Cr | Open |
| 27 Jan 2020 | Karnataka Bank Ltd. | ₹4.75 Cr | Open |
How Many Employees Work at Deltaspharma India?
Deltaspharma India has a workforce of 22 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deltaspharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deltaspharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.